Tensegrity and type I dermal dendrocytes in acromegaly

European Journal of Clinical Investigation

Volumn 35, Issue 2, 2005, Pages 133-139

  Quatresooz, P ^a   Hermanns Le T ^a   Ciccarelli, A ^a   Beckers, A ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Acromegaly; Dermal dendrocyte; Dermis; Growth hormone; Somatostatin analogue; Tensegrity

Indexed keywords

ACID GLYCOSAMINOGLYCAN; BLOOD CLOTTING FACTOR 10A; COLLAGEN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; CELL COUNT; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMAL DENDROCYTE; DISEASE DURATION; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RADIOTHERAPY; SKIN BIOPSY; SKIN CELL; STATISTICAL ANALYSIS; CELL SHAPE; CELL SIZE; DERMIS; MIDDLE AGED; PATHOLOGY; SKIN DISEASE;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; CELL SHAPE; CELL SIZE; DERMIS; FEMALE; HORMONES; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; SKIN DISEASES;

EID: 13544252455     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01461.x     Document Type: Article

References (40)

1. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly: clinical and biochemical features in 500 patients. Medicine 1994;73:233-40.
2. Thiboutot DM. Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab 1995;80:3082-7.
3. Centurion SA, Schwartz RA. Cutaneous signs of acromegaly. Int J Dermatol 2002;41:631-4.
4. Matsuoka LY, Wortsman J, Kupchella CE, Eng A, Dietrich JE. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 1982;142:1820-3.
5. Jorgensen PH, Andreassen TT, Jorgensen KD. Growth hormone influences collagen deposition and mechanical strength of intact rat skin. Acta Endocrinol 1989;120:767-72.
6. Hermanns-Lê T, Quatresooz P, Arrese JE, Piérard-Franchimont C, Beckers A, Piérard GE. Skin in acromegaly. Dermatol Actual 2003;75:16-9.
7. Braham C, Betea D, Piérard-Franchimont C, Beckers A, Piérard GE. Skin tensile properties in patients treated for acromegaly. Dermatology 2002;204:325-9.
8. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of growth hormone in men over 60 year old. N Engl J Med 1990;323:1-6.
9. Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE. Mechanical properties of skin in recombinant human growth factor abusers among adult body builders. Dermatology 1996;192:389-92.
10. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ. Localization of the growth hormone receptor/ binding protein in skin. J Endocrinol 1990;126:467-72.
11. Granot I, Halevy O, Hurwitz SA, Pines M. Growth hormone and insulin-like growth factor I regulate collagen gene expression and extracellular collagen in cultures of avian skin fibroblasts. Mol Cell Endocrinol 1991;80:1-9.
12. Oakes SR, Haynes KM, Waters MJ, Herington AC, Werther GA. Demonstration and localization of growth hormone receptor in human skin and skin fibroblast. J Clin Endocrinol Metab 1992;75:1368-73.
13. Tavakkol A, Elder JT, Griffiths CEM, Cooper KD, Talwar H, Fischer GJ, et al. Expression of growth hormone receptor insulin-like growth factor (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992;99:343-9.
14. Batch JA, Mercuri FA, Edmondson SR, Werther GA. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 1994;79:1444-9.
15. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrinol Rev 2000;21:457-87.
16. Ingber DE. Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci 1993;104:613-27.
17. Ingber DE, Dike L, Hansen L, Karp S, Liley H, Maniotis A, et al. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol 1994;150:173-224.
18. Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol 1997;59:575-99.
19. Fluck J, Querfeld C, Cremer A, Niland S, Krieg T, Solberg S. Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol 1998;110:153-7.
20. Chiquet M. Regulation of extracellular gene expression by mechanical stress. Matrix Biol 1999;18:417-26.
21. Grinnell F, Zhu M, Carlson MA, Abrams JM. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 1999;248:608-19.
22. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signaling and mechanical loading. Trends Cell Biol 2000;10:362-5.
23. Kassler D, Dethlefsen S, Haase I, Plomann M, Hirche F, Krieg T, et al. Fibroblasts in mechanically stressed collagen lattices assume a 'synthetic' phenotype. J Biol Chem 2001;276:36575-85.
24. Niland S, Cremer A, Fluck J, Eble JA, Krieg T, Solberg S. Contraction-dependent apoptosis of normal dermal fibroblasts. J Invest Dermatol 2001;116:686-92.
25. Vogel WF. Collagen-receptor signaling in health and disease. Eur J Dermatol 2001;11:506-14.
26. Silver FH, Siperko LM, Seehra GP. Mechanobiology of force transduction in dermal tissue. Skin Res Technol 2003;9:3-23.
27. Mosher DF, Schad PE. Cross-linking of fibronectin to collagen by blood coagulation Factor XIII a. J Clin Invest 1979;64:781-7.
28. Paye M, Nusgens BV, Lapière ChM. Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. Haemostasis 1989;19:274-83.
29. Paye M, Nusgens BV, Lapière ChM. Factor XIII of blood coagulation decreases the susceptibility of collagen precursors of proteolysis. Biochim Biophys Acta 1991;1073:437-41.
30. Marzano AV, Federici AB, Gasparini G, Mannucci PM, Caputo R, Berti E. Coagulation factor XIII, endothelial damage and systemic sclerosis. Eur J Dermatol 2000;10:14-7.
31. Arrese Estrada J, Piérard GE. Factor XIII a-positive dendrocytes and the dermal microvascular unit. Dermatologica 1990;180:51-3.
32. Cerio R, Spaull J, Oliver GF, Wilson Jones E. A study of Factor XIII a and Mac 387 immunolabeling in normal and pathological skin. Am J Dermatopathol 1990;12:221-33.
33. Piérard GE, Arrese Estrada E, Piérard-Franchimont C, Deleixhe-Mauhin F. Is there a link between dendrocytes, fibrosis and sclerosis? Dermatologica 1990;181:264-5.
34. Nestle FO, Nickoloff BJ. A fresh morphological and functional look at dermal dendritic cells. J Cutan Pathol 1995;22:385-93.
35. Hermanns-Le T, Paquet P, Piérard-Franchimont C, Arrese JE, Piérard GE. Regulatory function of factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus reaction. A Hypothesis Dermatol 1999;198:184-6.
36. Gilmour TK, Wilkinson B, Breit SN, Kossard S. Analysis of dendritic cell populations using a revised histological staging of morphœa. Br J Dermatol 2000;143:1183-92.
37. Hermanns-Lê T, Piérard GE. Factor XIII a-positive dendrocyte rarefaction in Ehlers-Danlos syndrome, classical type. Am J Dermatopathol 2001;23:427-30.
38. Penneys NS, Rademaker B, Jackson IT, Fasching MC. Loss of Factor XIII a in pig dermis during tissue expansion. J Dermatol Sci 1991;2:62-5.
39. Hermanns-Lê T, Uhoda I, Piérard-Franchimont C, Piérard GE. Factor XIIIa-positive dermal dendrocytes and shear wave propagation in human skin. Eur J Clin Invest 2002;32:847-51.
40. Barkan AL, Beitins IZ, Kelch KP. Plasma insulin-like growth factor-1/somatomedin-C in acromegaly: correlation with the degree of growth hormone secretion. J Clin Endocrinol Metab 1988;67:69-73.